Literature DB >> 2427541

Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

E C Böttger, T Hoffmann, U Hadding, D Bitter-Suermann.   

Abstract

Guinea pigs genetically deficient in the second (C2) or fourth component of complement (C4) generally appear healthy in contrast to humans with a C2 or C4 deficiency. However, upon investigation of these genetic deficiencies in guinea pigs for signs of dysregulation in the humoral immune system and especially autoantibodies, many complement-deficient guinea pigs (greater than 50%) had elevated levels of serum IgM and higher concentrations of anti-hapten (dinitrophenyl) antibodies as signs of polyclonally stimulated antibody synthesis. In addition, a significant number of the complement-deficient animals, on average 30%, had IgM rheumatoid factors in their sera compared with less than 1% of the normal animals. These observations, therefore, indicate that guinea pigs, genetically deficient in C2 or C4, show characteristics of immune complex disease in general.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427541      PMCID: PMC423652          DOI: 10.1172/JCI112628

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  A new complement function: solubilization of antigen-antibody aggregates.

Authors:  G W Miller; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Prevention of immune precipitation by purified components of the alternative pathway.

Authors:  J K Naama; E Holme; E Hamilton; K Whaley
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

3.  Preferential production of IgG2 anti-hapten antibody in guinea pigs immunized with 2,4-dinitrophenylated lipopolysaccharides of Escherichia coli.

Authors:  K Furuichi; M Kato; T Nakamura; J Koyama
Journal:  J Biochem       Date:  1974-11       Impact factor: 3.387

4.  Immunologic tolerance in C4 deficient guinea pigs.

Authors:  B E Cohen; I Green; J M Davie
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

5.  Spontaneous renal lesions and glomerular deposits of IgG and complement in guinea pigs.

Authors:  R W Steblay; U Rudofsky
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

6.  IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors.

Authors:  J B Natvig; P I Gaarder; M W Turner
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

7.  Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis.

Authors:  R S Panush; N E Bianco; P H Schur
Journal:  Arthritis Rheum       Date:  1971 Nov-Dec

8.  The response of lymphocytes from non-immunized humans to antigen-antibody complexes.

Authors:  N Bloch-Shtacher; K Hirschhorn; J W Uhr
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

9.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.

Authors:  T A Gaither; D W Alling; M M Frank
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

10.  In vivo studies in C4-deficient guinea pigs.

Authors:  L Ellman; I Green; F Judge; M M Frank
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The role of complement in the acquired immune response.

Authors:  C H Nielsen; E M Fischer; R G Leslie
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

2.  Defective solubilization of immune complexes and activation of the complement system in patients with pulmonary tuberculosis.

Authors:  P Senbagavalli; S T Geetha; P Venkatesan; V D Ramanathan
Journal:  J Clin Immunol       Date:  2009-05-27       Impact factor: 8.317

Review 3.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

4.  Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.

Authors:  S S Levinson; J O Goldman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 5.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

6.  Classical pathway of complement activation in mammalian kidneys.

Authors:  J Zwirner; E Felber; R Burger; D Bitter-Suermann; G Riethmüller; H E Feucht
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

7.  Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.

Authors:  Z Chen; S B Koralov; G Kelsoe
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

8.  Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.

Authors:  R J Quigg; C He; A Lim; D Berthiaume; J J Alexander; D Kraus; V M Holers
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

Review 9.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.